Chapter 14
Chapter 14
Chapter 14
Chapter 14
website. Thank you!
1
Why Use Multiples?
• A careful multiples analysis—comparing a company’s multiples versus those
of comparable companies—can be useful in improving cash flow forecasts
and testing the credibility of DCF-based valuations.
2
What Are Multiples?
• Multiples such as the enterprise-value-to-revenue ratio and the enterprise-value-to-
EBITA ratio are used to compare the relative valuations of companies. Multiples
normalize market values by revenues, profits, asset values, or nonfinancial statistics.
1
Deviation = Standard deviation/median.
3
Session Overview
3. Use the right peer group. A set of industry peers is a good place to start.
Refine the sample to peers that have similar outlooks for long-term growth and
return on invested capital (ROIC).
4
Enterprise Value to EBITA
g
EBITA(1-T) 1
Substitute EBITA(1 − T) Value ROIC
for NOPLAT. WACC g
5
Enterprise Value to EBITA
• Let’s use the formula to predict the enterprise-value-to-EBITA multiple for a
company with the following financial characteristics:
• Consider a company growing at 5 percent per year and generating a 15
percent return on invested capital. If the company has an operating tax rate
at 30 percent and a 9 percent cost of capital, what multiple of EBITA should
it trade at?
g
(1 T )1
Value ROIC
EBIT WACC g
5%
(1 .30)1
Value 15%
11 .7
EBIT 9% 5%
6
Distribution of EV to EBITA
Number of observations
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
7
Why EV to EBITA and Not Price to Earnings?
• A cross-company multiples analysis should highlight differences in performance, such
as differences in ROIC and growth, not differences in capital structure.
• Although no multiple is completely independent of capital structure, an enterprise value
multiple is less susceptible to distortions caused by the company’s debt-to-equity
choice. The multiple is calculated as follows:
• Consider a company that swaps debt for equity (i.e., raises debt to repurchase equity).
• EBITA is computed pre-interest, so it remains unchanged as debt is swapped
for equity.
• Swapping debt for equity will keep the numerator unchanged as well. Note,
however, that EV may change due to the second-order effects of signaling,
increased tax shields, or higher distress costs.
8
Why EV to EBITA and Not Price to Earnings?
• To show how capital structure distorts the P/E, consider four companies, named A
through D. Companies A and B trade at 10 times enterprise value to EBITA, and
Companies C and D trade at 25 times enterprise value to EBITA.
$ million
9
Why EBITA and Not EBITDA?
profitability; they differ only in size. EBIT Company A Company B Company C Company A+B Company C
Revenues 375 125 500 500 500
• Since all three companies generate the Cost of sales (150) (50) (200) (200) (200)
Depreciation (75) (25) (100) (100) (100)
same level of operating performance, Amortization
EBIT
−
150
−
50
−
200
(25)
175
−
200
10
Why EBITA and Not EBITDA?
• Many financial analysts use multiples of EBITDA, rather than EBITA, because
depreciation is a noncash expense, reflecting sunk costs, not future investment.
• But EBITDA multiples have their own drawbacks. To see this, consider two companies,
which differ only in outsourcing policies. Because they produce identical products at
the same costs, their valuations are identical ($3,000).
• What is each companies EV-to-EBITDA multiple and why are they different?
$ million
11
Use Forward-Looking Multiples
12
Use Forward-Looking Multiples
• To build a forward-looking multiple, choose a forecast year for EBITA that best represents
the long-term prospects of the business.
• In periods of stable growth and profitability, next year’s estimate will suffice. For
companies generating extraordinary earnings (either too high or too low) or for
companies whose performance is expected to change, use projections further out.
Pharmaceuticals: Backward- and Forward-Looking Multiples, December 2007
Merck 38 16 12
Bristol- Myers Squibb 27 17 12
Whereas historical Abbott 24 16 12
the forward-looking
P/E ratios across Eli Lilly 20 13 12
Novartis 20 17 13
EV-to-EBITA
pharmaceutical
Pfizer 19 13 13 multiples are nearly
companies show Johnson & Johnson 18 15 12 identical.
significant variation… Sanofi-Aventis 16 13 12
GlaxoSmithKline 14 15 12
Wyeth 13 12 12
AstraZeneca 12 15 12
Schering-Plough N/A2 16 11
1
Consensus analyst forecast.
2
Schering-Plough recorded loss in 2007, so no multiple is reported.
13
Session Overview
3. Use the right peer group. A set of industry peers is a good place to start.
Refine the sample to peers that have similar outlooks for long-term growth and
return on invested capital (ROIC).
14
Calculate the Multiple in a Consistent Manner
• There is only one approach to building an enterprise-value-to-EBITA
multiple that is theoretically consistent. Enterprise value must include all
investor capital but only the portion of value attributable to assets that
generate EBITA.
15
Consistency: Nonoperating Assets
16
Consistency: Include All Financial Claims
17
Advanced Adjustments
For companies with rental expense or pension assets, two additional
adjustments can be made.
1. The use of operating leases leads to artificially low enterprise value (missing debt)
and EBITA (lease interest is subtracted pre-EBITA). Although operating leases affect
both the numerator and denominator in the same direction, each adjustment is of a
different magnitude.
2. To adjust enterprise value for pensions, add the present value of unfunded pension
liabilities to debt plus equity. To remove gains and losses related to plan assets, start
with EBITA, add back pension expense, and deduct any service costs.
18
Session Overview
3. Use the right peer group. A set of industry peers is a good place to start.
Refine the sample to peers that have similar outlooks for long-term growth and
return on invested capital (ROIC).
19
Selecting a Robust Peer Group
20
Expect Variation Even within an Industry
21
ROIC and Growth Drive Variation
• The companies below fall into three performance buckets that align with different
multiples. The companies with the lowest margins and low growth expectations had
multiples of 7×. The companies with low growth but high margins had multiples of 9×.
Finally, the companies with high growth and high margins had multiples of 11× to 13×.
22
Closing Thoughts
A multiples analysis that is careful and well reasoned not only will provide a useful check of
your discounted cash flow (DCF) forecasts but also will provide critical insights into what
drives value in a given industry. A few closing thoughts about multiples:
1. Similar to DCF, enterprise value multiples are driven by the key value drivers, return
on invested capital and growth. A company with good prospects for profitability and
growth should trade at a higher multiple than its peers.
2. A well-designed multiples analysis will focus on operations, will use forecasted
profits (versus historical profits), and will concentrate on a peer group with similar
prospects.
• P/E ratios are problematic, as they commingle operating, nonoperating, and
financing activities, which leads to misused and misapplied multiples.
3. In limited situations, alternative multiples can provide useful insights. Common
alternatives include the price-to-sales ratio, the adjusted price-earnings growth
(PEG) ratio, and multiples based on nonfinancial (operational) data.
23